Med-IQ Logo
Get CME/CE

Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.

Course Listings: Nephrology

All Results (4)
Format: Live Events (0) Online Activities (4)

Fabry Disease: When to Treat

View Course

Format: E-Publication

    Maximum Credits:
  • 0.75 AMA PRA Category 1 Credit(s)

Course Description: This 45-minute, CME-certified digital publication discusses the variability of Fabry disease (FD) manifestations. In addition, it presents management approaches for patients with FD, including disease monitoring and comprehensive therapy.


CKD-MBD: Merging Science and Patient-Centered Care

View Course

Format: E-publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This 30-minute, CME-certified publication reviews the pathophysiology underlying chronic kidney disease–mineral and bone disorder (CKD-MBD), focusing on phosphate metabolism, effects on calcium and fibroblast growth factor 2, and associations with cardiovascular disease. Guideline recommendations, the role of phosphate-binding compounds, and strategies for…More


Diagnosis and Treatment of Primary Aldosteronism: How Aggressive Should We Be?

View Course

Format: Webcast

    Maximum Credits:
  • 0.75 AMA PRA Category 1 Credit(s)

Course Description: In this Webcast, faculty discuss primary aldosteronism as a common cause of secondary hypertension, explain the diagnostic algorithm for patients suspected of having primary aldosteronism, and explore the surgical and medical treatment options available for patients with a positive diagnosis.


Looking Beyond the Liver: Hepatitis C, Kidney Disease, and the Nephrologist

View Course

Format: E-publication

    Maximum Credits:
  • 0.5 AMA PRA Category 1 Credit(s)

Course Description: This online publication provides physicians with improved knowledge of the interaction between hepatitis C virus and chronic kidney disease, as well as the associated patient outcomes. It also explores the impact of various stages of renal dysfunction on patient outcomes and discusses choosing individualized direct-acting antiviral regimens based on available…More